India is home to the world’s third largest population of people with HIV/AIDS, with approximately 2.5 million people living with the disease, of which fewer than 49% have access to treatment (UNAIDS Data). Recognizing the critical need to further increase access to HIV/AIDS care in India, Mylan launched its domestic business in 2012 with a comprehensive portfolio of ARVs, all of which are manufactured at Mylan’s state-of-the-art facilities in India.
The product database is intended as a general reference source only and is not a substitute for qualified medical care from a licensed physician.